Association between Daytime Activity, Fatigue, Sleep, Anxiety, Depression, and Symptom Burden in Advanced Cancer Patients: A Preliminary Report

被引:48
作者
Yennurajalingam, Sriram [1 ]
Tayjasanant, Supakarn [1 ,2 ]
Balachandran, Dave [4 ]
Padhye, Nikhil S. [5 ]
Williams, Janet L. [1 ]
Liu, Diane D. [3 ]
Frisbee-Hume, Susan [1 ]
Bruera, Eduardo [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Unit 1414, 1515 Holcombe Blvd, Houston, TX 77030 USA
[2] Mahidol Univ, Siriraj Hosp, Fac Med, Siriraj Palliat Care Ctr, Bangkok, Thailand
[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Pulm Med, Houston, TX 77030 USA
[5] Univ Texas Houston, Hlth Sch Nursing, Res Ctr Nursing Res, Houston, TX USA
基金
美国国家卫生研究院;
关键词
QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; BREAST-CANCER; LUNG-CANCER; CONTROLLED METHYLPHENIDATE; FUNCTIONAL ASSESSMENT; HOSPITAL ANXIETY; CONTROLLED-TRIAL; RESPONSE-SHIFT; SURVIVORS;
D O I
10.1089/jpm.2015.0276
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: There is limited research in advanced cancer patients (ACP) regarding association between objectively measured daytime activity and sleep (as measured by actigraphy), patient characteristics, and cancer symptoms (fatigue, sleep, anxiety, depression, cachexia, and symptom distress scores [SDSs]). Objectives: Our aim of the study was to determine the association between mean daytime activity (MDTA) and the following items: fatigue (FACIT-F), SDSs (Edmonton Symptom Assessment Scale [ESAS]), sleep quality (Pittsburg Sleep Quality Index [PSQI]), objective sleep variables (OSV) (sleep onset, sleep efficacy, wake after sleep onset, total sleep time), anxiety and depression (Hospital Anxiety and Depression Scale [HADS]), body composition scores, and overall survival (OS). We also examined the association between sleep [PSQI and OSV scores] and FACIT-F, HADS, and ESAS. Methods: Secondary analysis of a recent clinical trial of cancer-related fatigue in advanced cancer (NCT00424099). Association between MDTA and OSV (measured by actigraphy) during the first week of the study and patient characteristics, symptoms (FACIT-F, ESAS, HADS, and PSQI), and OS were analyzed. Results: Seventy-nine eligible patients were evaluable. The median age was 57 years. Median MDTA was 248.43 counts/minute. Multivariate analysis shows that low MDTA was significantly associated with age, gender, Functional Assessment of Cancer Therapy (FACT)-Functional Well-Being (FWB), ESAS dyspnea, HADS-anxiety, and total sleep time. MDTA was not associated with FACIT-F (p = 0.997) and OS (p = 0.18). Sleep quality (PSQI) was significantly associated with FACIT-F, HADS, ESAS anxiety, and depression, but none of these variables was associated with OSV. Conclusion: In ACP, lower MDTA was significantly associated with age, gender, FACT-FWB, ESAS dyspnea, HADS-anxiety, and total sleep time. Both sleep quality and cancer-related fatigue scores were strongly associated with depression and anxiety. More research is needed.
引用
收藏
页码:849 / 856
页数:8
相关论文
共 56 条
[1]  
Berger A M, 2000, Oncol Nurs Forum, V27, P1443
[2]   Values of sleep/wake, activity/rest, circadian rhythms, and fatigue prior to adjuvant breast cancer chemotherapy [J].
Berger, Ann M. ;
Farr, Lynne A. ;
Kuhn, Brett R. ;
Fischer, Patricia ;
Agrawal, Sangeeta .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2007, 33 (04) :398-409
[3]   Sleep Misperception in Healthy Adults: Implications for Insomnia Diagnosis [J].
Bianchi, Matt T. ;
Wang, Wei ;
Klerman, Elizabeth B. .
JOURNAL OF CLINICAL SLEEP MEDICINE, 2012, 8 (05) :547-+
[4]   Healthy Hearts-and the Universal Benefits of Being Physically Active: Physical Activity and Health [J].
Blair, Steven N. ;
Morris, Jeremy N. .
ANNALS OF EPIDEMIOLOGY, 2009, 19 (04) :253-256
[5]  
Boyle T, 2015, PSYCHO-ONCOLOGY, DOI [10.1002/pon.4027, DOI 10.1002/pon.4027.]
[6]   How sedentary and physically active are breast cancer survivors, and which population subgroups have higher or lower levels of these behaviors? [J].
Boyle, Terry ;
Vallance, Jeff K. ;
Ransom, Emily K. ;
Lynch, Brigid M. .
SUPPORTIVE CARE IN CANCER, 2016, 24 (05) :2181-2190
[7]   The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer [J].
Brown, DJF ;
McMillan, DC ;
Milroy, R .
CANCER, 2005, 103 (02) :377-382
[8]   Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: A preliminary report [J].
Bruera, E ;
Driver, L ;
Barnes, EA ;
Willey, J ;
Shen, L ;
Palmer, JL ;
Escalante, C .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (23) :4439-4443
[9]   Patient-controlled methylphenidate for cancer fatigue: A double-blind, randomized, placebo-controlled trial [J].
Bruera, E ;
Valero, V ;
Driver, L ;
Shen, LR ;
Willey, J ;
Zhang, T ;
Palmer, JL .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (13) :2073-2078
[10]   Methylphenidate and/or a Nursing Telephone Intervention for Fatigue in Patients With Advanced Cancer: A Randomized, Placebo-Controlled, Phase II Trial [J].
Bruera, Eduardo ;
Yennurajalingam, Sriram ;
Palmer, J. Lynn ;
Perez-Cruz, Pedro E. ;
Frisbee-Hume, Susan ;
Allo, Julio A. ;
Williams, Janet L. ;
Cohen, Marlene Z. .
JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (19) :2421-2427